about
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbot...
Read More
4.84
0.49
(11.26%)
58,230.3
XNAS Volume
XNAS 08 May, 2026 4:00 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
BioAtla Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..